Navigation Links
OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
Date:12/15/2008

/p>

OmegaGenesis, based in California and Minnesota, was founded in February of 2008 with seed capital from venture investors. The company anticipates to advance its current programs through much of the preclinical stages on existing capital, then pursue another round of financing in the second quarter of 2009.

In addition to Mr. Raza, OmegaGenesis will be led by Salah Sedarous, Ph.D., chief technology officer and co-founder, Don Morrison, executive vice president of corporate development and Dennis Kushner, executive vice president of operations. Riaz Karamali and Karen Cannan of Sheppard Mullin lead legal affairs and patent filings.

OmegaGenesis will continue an ongoing collaboration with Debabrata Mukhopadhyay, Ph.D., head of the Mayo Clinic research team studying the properties of a number of rare earth element nano-materials as well as angiogenesis. Dr. Mukhopadhyay's research has demonstrated that europium hydroxide nanorods promote growth of new blood vessels. The europium hydroxide nanorods are between 100 to 300 nanometers in length and one and 30 to 50 nanometers in diameter. One nanometer is 10(-9) meter or about 1/100,000 of the diameter of a human hair.

"Combining nano-materials technology, and the wealth of existing knowledge about angiogenesis, OmegaGenesis is pioneering the development of nano-scale biomedical therapies," added Raza. "Using this novel approach, the company is moving towards treatments that are safer and less invasive than conventional medicines."

About OmegaGenesis

OmegaGenesis is a biotechnology company based in Gilroy, Calif., and Rochester, Minn. OmegaGenesis was founded in 2008 to bring Mayo Clinic core research and resulting products to market based on the idea that controlling blood vessel growth would improve human body management for a diverse set of medical applications ranging from ca
'/>"/>

SOURCE OmegaGenesis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
2. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
3. Oregon Tourism Commission Unveils New Online Customer Service Training Program
4. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
5. Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
6. Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders
7. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
8. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
9. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Southfield Capital, ... firm, announced today that it completed a ... Communications. BioPharm specializes in the development and multi-channel ... pharmaceutical and biotechnology industries. Through ... shareholders half of their invested capital and ...
(Date:5/4/2015)... BOSTON , May 4, 2015 PAREXEL International ... be presenting at the UBS Healthcare Conference on Monday, May ... Senior Vice President and Chief Financial Officer will be making ... a.m. ET. A live webcast of the presentation ... at www.PAREXEL.com in the Upcoming Events portion of ...
(Date:5/4/2015)... 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... roles, appointing  Donna M. Hughes, as Senior Vice President, ... Senior Vice President, Chief Compliance Officer. Both Ms. Hughes ... Chief Executive Officer, Fred Wilkinson . ... the Impax team," said Fred Wilkinson , President ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2PAREXEL International to Present at UBS Healthcare Conference 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... , , SAN FRANCISCO, Aug. 21 ... first annual "Bridge to Hope," an all-day music festival set to be held ... from 11:00 a.m. to 7:00 p.m. The event will also include an ... selection of gourmet fare from a number of the city,s favorite eateries. , ...
... , , , ... Bay(R) Pharmaceuticals , Inc. (NYSE-Amex: NBY ), a ... prevention of a wide range of bacterial, viral, and fungal infections, ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA. ...
Cached Medicine Technology:Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 2Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 3Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 4Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 5NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 2NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 3
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Ticket Down ... 2015 International Champions Cup (ICC) . While the World ... and is held every four years, the International Champions Cup ... the tournament saw the all-time attendance record for soccer in ... from the Big House at the University of Michigan. This ...
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... 04, 2015 Ticket Down is a reputable ... Paul Jones Arena in Charlottesville, VA. McCartney is ... the music business and this beloved performer continues to roll ... former member of two legendary groups: Wings and The Beatles, ... business since 2013 on the “Out There” tour and has ...
(Date:5/4/2015)... 04, 2015 New findings released today ... Association (ABTA) show that people diagnosed with a brain ... options, including clinical trials, at the time of diagnosis, ... difficult decisions about their course of treatment. The release ... first nationwide brain tumor volunteer network, the ABTA CommYOUnity™, ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Pricing Healthcare ... to $3,000) of one patient receiving care at St. ... The procedure must be performed by July 15th, 2015, ... pay in full up front and forego the filing of ... more economically burdensome every year, and it devastates more and ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... (BRONX, NY) Recurrent and metastatic endometrial and ... have spread to other organs and typically have developed ... chemotherapy may not be able to endure more chemo. ... Yeshiva University have shown that a combination of two ...
... Four associations representing the state,s 114 hospitals have ... budget for 2010.Among other principles, the groups urged the ... funds and agreed on a minimum floor that all ... agreement was shared today with members of the state ...
... Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM ) ... operations. This restructuring will direct resources to business opportunities ... of proprietary compounds. With this change, the Company ... for Pharmaceutical Development & Chief Medical Officer is being ...
... acid, also in nuts, limits wrinkling , , TUESDAY, April ... are nutritious. But new research shows that a compound found ... and repair skin damage caused by the sun. , Researchers ... strawberries, cranberries and pomegranates, to human skin cells in the ...
... get worse as you get older may actually be a ... that senior citizens who think older people should perform poorly ... who do not buy in to negative stereotypes about aging ... month, psychology professor Dr. Tom Hess and a team of ...
... April 21 NBTY, Inc. (NYSE: NTY ) ( ... nutritional supplements, today announced it will web cast a conference call ... ( www.NBTY.com ), on Friday, April 24, 2009 at ... fiscal second quarter will be issued at 4:30 PM (ET) on ...
Cached Medicine News:Health News:New treatment shows promise against recurrent gynecologic cancers 2Health News:Hospital Groups Stand United on State Budget 2Health News:Hospital Groups Stand United on State Budget 3Health News:Hospital Groups Stand United on State Budget 4Health News:Immtech to Reorganize Research and Development Operations 2Health News:Immtech to Reorganize Research and Development Operations 3Health News:Compound in Berries May Lessen Sun Damage 2Health News:Think memory worsens with age? Then yours probably will 2Health News:NBTY to Web Cast Fiscal Second Quarter Conference Call 2Health News:NBTY to Web Cast Fiscal Second Quarter Conference Call 3
... procedures where stability, access, and precise, ... cantilevered low attenuation carbon fiber tabletop ... radiolucent area is free of cross ... unobstructed C-Arm positioning. Functional design provides ...
...
... Immunoassay Control is a ... designed to complement the ... Immunoassay Plus Controls. This ... to include more complex ...
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: